W Wang, Z Ye, H Gao, D Ouyang - Journal of Controlled Release, 2021 - Elsevier
In recent decades pharmaceutics and drug delivery have become increasingly critical in the pharmaceutical industry due to longer time, higher cost, and less productivity of new …
N Wang, Y Zhang, W Wang, Z Ye, H Chen, G Hu… - Advanced Drug Delivery …, 2023 - Elsevier
The eyes possess sophisticated physiological structures, diverse disease targets, limited drug delivery space, distinctive barriers, and complicated biomechanical processes …
A Schuhmacher, A Gatto, M Hinder, M Kuss… - Drug discovery today, 2020 - Elsevier
Highlights•We have investigated the state of artificial intelligence in pharmaceutical R&D.•We have outlined here a risk and reward perspective regarding digital R&D.•The …
Highlights•To understand the AI technologies that are used in pharmaceutical research and development (R&D), we analyzed 271 AI-related publications from the top 20 …
Highlights•Alphabet, Amazon, Apple, IBM, and Microsoft have all built complex business models to access and penetrate the healthcare markets.•For example, Google focuses …
Artificial intelligence (AI) has emerged as a powerful tool to revolutionize the healthcare sector, including drug delivery and development. This review explores the current and future …
Take heart. AI is none of those things. It's part of our everyday lives, and it has the power to transform your business. This book will put AI, big data, the cloud, robotics, and smart …
At present, due to increased costs, decreased productivity, and lack of breakthrough technologies, many pharmaceutical firms face various challenges in their research and …
Highlights•The Global Financial Crisis (2007–2008) shifted the worldwide markets.•This permitted Big Pharma to experiment with new R&D models for open innovation.•Ten years …